George Tan

Association Discovery Approach in Healthcare Big Data to Identify Drug Safety and Drug Repurposing Signals Check out this new pub: ascpt.onlinelibrary.wiley.com/doi/10.1002/cp… @giwebb @JenniIlomaki @CentMedUseSafet @MIPS_Australia

New Spotlight Commentary: Using real‐world data for real‐world evidence generation to advance drug repurposing Check out this new pub: doi.org/10.1002/bcp.70… @JenniIlomaki @CentMedUseSafet

Register now for the @ASCEPTanz #Pharmacoepidemiology SIG webinar masterclass with Dr. Jenna Wong on using Machine Learning to Support Activities for Post-Market Drug Safety Surveillance. Sep 17th, 12 pm. Register now: monash.zoom.us/webinar/regist…

🧠Our 10-yr pre/post-#Alzheimer's disease study on medication use: bit.ly/medalz 💊While #symptomatic meds plateaued post-diagnosis for both AD & non-AD cohorts, #preventive meds declined in the AD cohort but continued to increase in the non-AD cohort. #deprescribing

Over 90% of #frail #nursinghome residents in 🇦🇺🇨🇳🇯🇵🇪🇸 who were most vulnerable to medication #sideeffects were prescribed #medications that may cause harm based on the #STOPPFrail criteria It's time to consider #deprescribing to optimise #medicationuse 🔖bit.ly/frailnh

Outcome-wide cohort study design to identify novel collateral benefits and new indications of SGLT-2 inhibitor Check out this new pub: doi.org/10.1002/cpt.31… @CentMedUseSafet @BakerResearchAu

@spaarkingo @CentMedUseSafet @MonashPharm Thanks Gopi! (and for the photo)

@ZANFINA @spaarkingo @CentMedUseSafet @MonashPharm Thanks Zanfina

@spaarkingo @_GeorgeTan @CentMedUseSafet @MonashPharm Congratulations George what an incredible accomplishment

Targeting COX2 to improve insulin resistance? We conducted an epi study to investigate this. Check out this new pub here: doi.org/10.1016/j.diab… @CentMedUseSafety @BakerResearchAu @NatalieTrevaski

Our latest #international #agedcare #research: doi.org/10.1007/s40520… 🇬🇸 #Australia: Ratio of symptomatic to preventive #medication use was higher with #frailty but lower with #age 🇯🇵 #Japan: Ratio remained consistent across #age & #frailty groups

New Drug Discovery Today review from @CentMedUseSafet shows big data can be used to identify existing medication for 'drug repurposing'. George Tan @CNI_lab Pete Lambert @CarlkRx @jenni_ilomaki monash.edu/pharm/about/ne…

How did COVID-19 affect prescription opioid use in Australia? Spotlight poster presented by @MonicaJung13 @IntPharmacoEpi #ICPE22 @DrSuziNielsen @MonashDFI @CentMedUseSafet @MonashAddiction

How are symptomatic and preventive medicines used in Australian and Japanese nursing homes by #frailty status? Check out this poster by @shin_liau presented @IntPharmacoEpi #ICPE22 @CentMedUseSafet @CRE_Frailty

@_GeorgeTan about to share his findings on the use of RWD for drug repurposing during lunch break @IntPharmacoEpi #icpe2022 @CentMedUseSafet @CarlkRx @SloanLab

Fabulous presentation at #ICPE22 by Dr @jenni_ilomaki on the 4C4D Study: Four Continents for #Dementia 👏 @CentMedUseSafet @MIPS_Australia @MonashUni

Kickstarting @ICPE22 with the first pre-conference session on a toolbox for professional empowerment in pharmacoepi!!

The Runner-up of the faculty #3MT finals is @AnnieP_Luo for her presentation "Bistriazine, a novel antimalarial" 👏👏👏

And the 1st place goes to... @shin_liau for her presentation "Focus on Frailty". Shin will represent the faculty at the Monash-wide #3MT finals in August. Congratulations!